Differences
This shows you the differences between two versions of the page.
Next revision | Previous revisionBoth sides next revision | ||
dia_global [2022/08/30 20:09] pamela created | — (current) | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ===== DIA Global ===== | ||
- | Expert PR Crisis Management Communications | ||
- | |||
- | For more than 50 years, DIA (the Drug Information Association) has served as a global forum for all those involved in health care product development and life cycle management to exchange knowledge and collaborate in a neutral setting. DIA is an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation. | ||
- | |||
- | ==== A History of Accomplishment ==== | ||
- | |||
- | DIA was founded in 1964 as a neutral global membership association dedicated to improving communication and collaboration in drug development. That goal remains the same today. | ||
- | |||
- | The organization was born out of a true need. DIA’s founding was closely tied to the 1962 passage of sweeping legislation passed in the United States in response to the finding that use of [[: | ||
- | |||
- | The neutral posture of DIA encourages active participation. Because membership spans all aspects of health care product development and life cycle management, members are free to collaborate fully as they explore fresh ideas and think outside of their traditional fields. Today, DIA is a worldwide organization in more than 80 countries with regional offices covering the Americas, Europe, Asia, the Middle East, and Africa. ((https:// |